Holen Sie sich die Stockscreener-App
89.23
1.91%
1.67
Handel nachbörslich:
89.23
Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten
BMO Capital Initiates Coverage on Zimmer Biomet With Market Perform Rating, $95 Price Target - marketscreener.com
Surgical Navigation System Report; Patent Leadership Led by the United States with 1,204 Patents In 230-Page Patent Landscape Covering Neurosurgery, Spinal, Orthopaedic, ENT, and Dental Navigation Applications - GlobeNewswire Inc.
Zimmer Biomet focuses on orthopedic growth. Investors watch long-term demand - Ad-hoc-news.de
Zimmer Biomet (ZBH) Coverage Initiated with Market Perform Ratin - GuruFocus
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zimmer Biomet To Acquire Iovera Pain Therapy Business For $140M - InkFreeNews.com
Zimmer Biomet focuses on orthopedic growth as investors weigh long-term demand - AD HOC NEWS
Zimmer Biomet stock holds focus on execution - AD HOC NEWS
Evercore ISI Adjusts Price Target on Zimmer Biomet to $110 From $120 - Moomoo
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet stock holds steady on thin coverage. Focus stays on execution. - AD HOC NEWS
Zimmer Biomet acquires rights to medical device for $140 million - Inside INdiana Business
Evercore Maintains Zimmer Biomet Holdings(ZBH.US) With Buy Rating, Cuts Target Price to $110 - Moomoo
JP Morgan Downgrades Zimmer Biomet Holdings (ZBH) - MSN
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating the Potential 12.84% Upside in the Healthcare Sector - DirectorsTalk Interviews
Enterprise value to revenue forward of Zimmer Biomet Holdings, Inc. – NYSE:ZBH - TradingView
Zimmer Biomet (ZBH) Stock Looks Cheap On Earnings But Faces Growth Doubts - Sahm
Zimmer Biomet Holdings Inc (ZBH) Shares Surge 3.9% -- What GF Sc - GuruFocus
ZBH News | ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) - ChartMill
Zimmer Biomet (ZBH) director awarded 389 Phantom Stock Units in deferred pay plan - Stock Titan
[Form 4] ZIMMER BIOMET HOLDINGS, INC. Insider Trading Activity - Stock Titan
Form 4 Zimmer Biomet Holdings Inc For: 2 July By Investing.com - Investing.com India
Zimmer Biomet (ZBH) director granted 317.369 cash-settled phantom stock units - Stock Titan
Zimmer Biomet (ZBH) director awarded 317.369 phantom stock units in cash-settled plan - Stock Titan
Phantom stock grant increases Zimmer Biomet (NYSE: ZBH) director units - Stock Titan
Zimmer Biomet (NYSE: ZBH) director receives cash-settled phantom stock grant - Stock Titan
Zimmer Biomet (ZBH) director receives new phantom stock unit award - Stock Titan
Medical device maker Zimmer Biomet to hire 500 in 3 years for tech centre in India - marketscreener.com
Enterprise value to EBIT forward of Zimmer Biomet Holdings, Inc. – NYSE:ZBH - TradingView
Zimmer Biomet (ZBH) Is Buying Pacira’s Iovera Device And Expanding Into Spasticity - Yahoo Finance
Zimmer Biomet Holdings | SD: Specialized disclosure report - Moomoo
‘Cool move’ by Zimmer part of med-tech’s tuck-in deals trend - BioWorld News
Pacira to Divest iovera Business to Zimmer Biomet in Up To $140M Deal - TradingView
Pacira BioSciences to divest its iovera° business to Zimmer Biomet - Medical Buyer
Zimmer Biomet to acquire iovera device from Pacira for $140m - Yahoo Finance
BTIG Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating - Moomoo
Persona IQ from Zimmer Biometsmart knee implant brings continuous data to US surgeons - AD HOC NEWS
A Look at Zimmer Biomet Holdings Inc (ZBH) After 5.6% Decline -- GF Value $126.11 vs Price $86.09 - GuruFocus
Zimmer Biomet Holdings, Inc.'s Stock Price Plummets to $86.09, Suffers a Sharp 5.64% Drop - Smartkarma
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MSN
Zimmer Biomet Holdings, Inc. agreed to acquire iovera ° Business of Pacira BioSciences from Pacira BioSciences, Inc. for $140 million. - marketscreener.com
Why is Zimmer Biomet stock sliding today? By Investing.com - Investing.com Canada
What is behind Zimmer Biomet stock's recent drop in value today - Traders Union
Pacira BioSciences (PCRX) Sells iovera° Business to Zimmer Biome - GuruFocus
Pacira divests iovera device to Zimmer Biomet for up to $140m - Investing.com
Pacira BioSciences stock rises on Zimmer Biomet deal By Investing.com - Investing.com South Africa
Pacira BioSciences stock rises on Zimmer Biomet deal - Investing.com UK
Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet - The Manila Times
Pacira BioSciences to Divest iovera° to Zimmer Biomet for Up to $140 Million - Quiver Quantitative
Pacira (NASDAQ: PCRX) divests iovera° business to Zimmer Biomet for up to $140M - Stock Titan
Pacira offloads iovera° for up to $140M, keeps spasticity program - Stock Titan
Zimmer Biomet secures $2.75 billion credit, shares under Wall Street scrutiny - AD HOC NEWS
Zimmer Biomet Holdings (ZBH) Secures New Credit Agreements to Bo - GuruFocus
The Persona Knee System from Zimmer Biomet Holdings Inc.modular design tailored to each joint - AD HOC NEWS
Is Zimmer Biomet stock underperforming the S&P 500? - MSN
Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Zimmer Biomet Expands Liquidity With New Credit Facilities - TipRanks
Zimmer Biomet Refinances With New $1.5B Five-Year and $1.25B 364-Day Facilities; 2025 Lines Ended - TradingView
Zimmer Biomet (ZBH) secures new five-year and 364-day credit lines - Stock Titan
Price to sales forward of Zimmer Biomet Holdings, Inc. – SWB:ZIM - TradingView
Price to earnings forward of Zimmer Biomet Holdings, Inc. – SWB:ZIM - TradingView
3.11%
1.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):